Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma (COMMAND)

This study has been terminated.
(Interim analysis-DSMB stated good safety profile but lack of efficacy)
Sponsor:
Information provided by (Responsible Party):
Verastem, Inc.
ClinicalTrials.gov Identifier:
NCT01870609
First received: May 29, 2013
Last updated: March 31, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: March 31, 2016